| Dr John Becton Carter, MD | |
|
920 Stanton L Young Blvd # Wp1140, Oklahoma City, OK 73104-5036 | |
| (405) 271-4351 | |
| (450) 271-8695 |
| Full Name | Dr John Becton Carter |
|---|---|
| Gender | Male |
| Speciality | Anesthesiology |
| Location | 920 Stanton L Young Blvd # Wp1140, Oklahoma City, Oklahoma |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114900040 | NPI | - | NPPES |
| 1430837-01 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207L00000X | Anesthesiology | F6512 (Texas) | Secondary |
| 207L00000X | Anesthesiology | 28021 (Oklahoma) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr John Becton Carter, MD Po Box 26901, Oklahoma City, OK 73126-0901 Ph: (405) 271-4351 | Dr John Becton Carter, MD 920 Stanton L Young Blvd # Wp1140, Oklahoma City, OK 73104-5036 Ph: (405) 271-4351 |
News Archive
Researchers have made an exciting breakthrough - developing a first-of-its-kind imaging tool to examine myelin damage in multiple sclerosis (MS). An extremely difficult disease to diagnose, the tool will help physicians diagnose patients earlier, monitor the disease's progression, and evaluate therapy efficacy.
Zalicus Inc. a biopharmaceutical company that discovers and develops novel treatments for patients suffering from pain and immuno-inflammatory diseases today announced the initiation of the SYNERGY trial, a Phase 2b clinical trial evaluating Synavive, a low-dose glucocorticoid with the potential for amplified immuno-inflammatory benefits, in patients with rheumatoid arthritis (RA).
A Web-based application developed by the Office of Naval Research (ONR) will form the basis of the nation's first Defense Department-wide system to track and manage human subject studies funded by the federal government, officials announced Aug. 6.
Vision Facilities Management Limited, a leading provider of integrated healthcare asset management software, announces the launch of a new two-way communication interface with ECRI Institute that will significantly improve the ability of hospital staff to manage medical device safety alerts and recalls.
Researchers have been seeking a safe and effective way to treat cognitive impairments associated with schizophrenia by enhancing N-methyl-D-aspartate (NMDA) glutamate receptors. Functional deficits in NMDA receptors may contribute to the underlying neurobiology of this disorder.
› Verified 1 days ago
Dr. Elizabeth Anne Williams, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 6201 Beaver Creek Rd, Oklahoma City, OK 73162 Phone: 405-210-4198 Fax: 405-703-7595 | |
Dr. Steven J Lantier, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 9500 Broadway Ext, Oklahoma City, OK 73114 Phone: 405-475-0680 | |
Dr. Martin J Lopez, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 4525 S Klein Ave, Ste 900, Oklahoma City, OK 73109 Phone: 405-636-1797 | |
Betty J Haywood, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 750 Ne 13th St, Oac 200, Oklahoma City, OK 73104 Phone: 405-271-4351 Fax: 405-271-8695 | |
Dr. Suhal S Mahid, MD, PHD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1000 N Lee Ave, Oklahoma City, OK 73102 Phone: 405-272-8000 | |
Dr. Lauren L. Fitzgerald, MD Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 4401 S Western Ave, Oklahoma City, OK 73109 Phone: 918-392-2944 Fax: 918-664-2521 | |
Sathish Ramanathan, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 920 Stanton L Young Blvd # Wp1140, Oklahoma City, OK 73104 Phone: 405-271-4351 Fax: 405-271-8695 |